A Phase 1/2 Trial of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma
暂无分享,去创建一个
J. Berenson | P. Rosen | A. Bessudo | M. Flam | Y. Nassir | R. Swift | R. Vescio | L. Stampleman | S. Eshaghian | L. Klein | T. Woliver